2024
2023
![](https://www.cellestia.com/wp-content/uploads/2021/03/Capture-444x315.png)
August 2023
Cellestia’s publication “The Efficacy of CB-103, a First-in-Class Transcriptional Notch Inhibitor, in Preclinical Models of Breast Cancer” is out in Cancers
Read more![](https://www.cellestia.com/wp-content/uploads/2023/06/pexels-vidal-balielo-jr-1250655-444x315.jpg)
June 2023
A new IIT Phase II trial is now open for patient recruitment at Dana-Farber Cancer Institute
Read more![](https://www.cellestia.com/wp-content/uploads/2023/06/pexels-anna-shvets-3845126-444x315.jpg)
May 2023
The Investigator Initiated Phase II Trial at MD Anderson Cancer Center combining CB-103 and Venetoclax for the treatment of rr/r-T-ALL patients is now open for recruitment
Read more![](https://www.cellestia.com/wp-content/uploads/2023/06/pexels-edward-jenner-4031418-444x315.jpg)
May 2023
CB-103 treatment in metastatic clear cell renal cell carcinoma shows promising results
Read more2022
![](https://www.cellestia.com/wp-content/uploads/2021/12/pexels-rfstudio-3825586-444x315.jpg)
June 2022
A case study shows contribution of Cellestia ’s CB-103 in achieving complete response in a relapse/refractor T-ALL patient
Read more2021
![](https://www.cellestia.com/wp-content/uploads/2021/12/pexels-karolina-grabowska-4021779-1-444x315.jpg)
December 2021
CB-103 has been granted an Orphan Designation for the treatment of Acute Lymphoblastic Leukaemia (ALL)
Read more![](https://www.cellestia.com/wp-content/uploads/2021/06/pexels-polina-tankilevitch-3735709-444x315.jpg)
November 2021
Cellestia presented its poster at SOHC – Swiss Oncology and Hematology Congress
Read more![](https://www.cellestia.com/wp-content/uploads/2021/06/pexels-photo-5726714-444x315.jpeg)
May 2021
Nature Reviews Drug Discovery Article “Advances in targeting ‘undruggable’ transcription factors with small molecules”
Read more2020
![](https://www.cellestia.com/wp-content/uploads/2020/12/Capture-444x315.png)
December 2020
Cellestia launches a new drug discovery program to target Transcription Factors
Read more![](https://www.cellestia.com/wp-content/uploads/2019/10/news-8-444x315.jpg)
October 2020
Article in “The Swiss Startup Ecosystem: Innovation in Chemistry and the Life Sciences”
Read more![](https://www.cellestia.com/wp-content/uploads/2020/09/pexels-photo-3740390-444x315.jpeg)
September 2020
Cellestia presented promising clinical data of its lead compound CB-103 at ESMO 2020
Read more![](https://www.cellestia.com/wp-content/uploads/2020/08/pexels-andrea-piacquadio-3760069-444x315.jpg)
August 2020